GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹3,328 Cr | ₹1,609 Cr | ₹3,877 Cr | ₹3,593 Cr | ₹3,159 Cr |
What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹3,328 Cr |
| Mar2024 | ₹1,609 Cr |
| Mar2023 | ₹3,877 Cr |
| Mar2022 | ₹3,593 Cr |
| Mar2021 | ₹3,159 Cr |
How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,328 Cr | 106.80 | |
| Mar2024 | ₹1,609 Cr | -58.49 | |
| Mar2023 | ₹3,877 Cr | 7.92 | |
| Mar2022 | ₹3,593 Cr | 13.75 | |
| Mar2021 | ₹3,159 Cr | - | |
Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,066.1 Cr | -0.5% | -1% | 31.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.5% |
-1% |
31.8% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses